Request Trial

Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 456

Articles by Marisa Woutersen

From the courtroom: Hikma v Amarin SCOTUS oral arguments
Pharma
From the courtroom: Hikma v Amarin SCOTUS oral arguments
The Supreme Court's first look at the skinny label dispute dug into key questions, from the role of the skinny label to who Hikma’s statements were really meant for, in one of the most important patent cases in years.   30 April 2026
EU court under pressure to define SPC limits in patent row
Europe
EU court under pressure to define SPC limits in patent row
An opinion has put pressure on the CJEU to clarify a long-running grey area that could change the game for how drug makers secure supplementary protection certificates across Europe.   24 April 2026
Amneal acquires biopharma ahead of $300bn patent wave
Americas
Amneal acquires biopharma ahead of $300bn patent wave
The US pharma giant is spending up to $1 billion to build an end-to-end biosimilar platform and is counting on a decade of expiring biologic patents to make it pay off.   23 April 2026
Careers
Litigator from Brown Rudnick moves firms to chair practice
A New Jersey firm appoints the high-stakes litigator as chair of its trademarks, trade secrets and copyright practice, bringing experience across patent, trade secret, trademark, trade dress, and copyright disputes.   21 April 2026
Americas
Penile implant maker’s $17m trade secret award unravels
The maker of a cosmetic penile implant has suffered at the Federal Circuit, after a ruling said its trade secrets claims are not protectable while leaving a counterfeiting finding intact.   20 April 2026
Americas
Appeals court eases Teva’s headache with reversal
A ruling that invalidated three of Teva's headache treatment patents has been thrown out, sending a long-running case back to the lower court.   17 April 2026
Careers
Simmons & Simmons makes senior Asia trademark hire
The Hong Kong partner brings more than 20 years’ experience and specialises in trademark strategy, cross-border enforcement, and brand protection across Asia and beyond.   17 April 2026
Americas
Cancer drug researcher hit with suit over mutation-targeting tools
The Cambridge biotech is accused of infringing six patents covering technologies used to target drug-resistant cancer mutations.   16 April 2026
Pharma
Novo Nordisk and OpenAI strike AI deal to boost drug discovery
The Danish pharma giant is turning to artificial intelligence as it faces patent expiry, falling shares and intensifying competition from Eli Lilly.   15 April 2026
Americas
Court narrows Mylan’s Copaxone suit but key claims survive
A US district court has allowed key elements of the generic drugmaker’s case against a rival to move forward, while drawing clear limits on how far the complaint can reach.   14 April 2026

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.